Coloplast A/S - Announcement no. 04/2025 - Interim Financial Report, H1 2024/25 ... Coloplast delivered 6% organic growth in Q2, impacted by the...
1 month ago

Positive Points · Coloplast AS (CLPBF) reported a 6% organic growth and a 27% EBIT margin before special items in the second quarter. · The...
1 month ago

Coloplast remains a leader in intimate healthcare with strong growth, innovation, and dividend support, despite recent weakness.
1 week ago

Average settlement amounts in transvaginal mesh claims in 2025 and how vaginal mesh lawsuits work after the class action lawsuit..
6 days ago

Last month, the Danish medtech company fired its CEO when results underperformed expectations. The firing came just days after a guidance...
3 weeks ago

As the company is entering into a new strategy period, the Board of Directors has decided to initiate the search for a new CEO to lead Coloplast...
1 month ago

The event will take place on Tuesday, 2 September 2025 at Clarion Hotel (Copenhagen airport)Ellehammersvej 20, 2770 Kastrupfrom 10.30...
3 weeks ago

Coloplast A/S Revised guidance for FY 2024/25 ... Coloplast revises the guidance on organic growth and EBIT margin before special items for FY...
1 month ago

Coloplast A/S - Interim Financial Report, Q1 2024/25 ... Coloplast delivered 8% organic growth and an EBIT margin¹ of 27% in Q1, in line with...
4 months ago

Coloplast divests core Skin Care product portfolio ... The divestment is part of a strategic initiative to simplify business operations and...
6 months ago